mention in seeking alpha, page-2

Sorry forgot to add the link!

a snippet of the article
Some notable contracts that PCT has worked on include Dendreon’s (DNDN) PROVENGE product, (which got FDA approval) and a host of other firms in cell therapy manufacturing, from inception through clinical trial pathway. PCT participated in Dendreon’s approval by providing the majority of their Phase 3b products to patients on both the east and west coast and now Dendreon has an approved cell therapy. PCT did their Phase 1 and 2 work as well. Prima Biomed is another firm which PCT worked with. It's working on Phase 3 ovarian cancer drug using dendritic cells.

Or you can read the whole thing here

http://seekingalpha.com/article/297380-neostem-may-have-the-right-mix-of-assets-to-excel-in-cell-therapies